• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝基喹诺酮稠合酰腙作为非小细胞肺癌药物的抗增殖活性。

Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents.

作者信息

Nandakumar Vandana, Sundarasamy Amsaveni, Adhigaman Kaviyarasu, Ramasamy Sentamil Selvi, Paulpandi Manickam, Kodiveri Muthukaliannan Gothandam, Narayanasamy Arul, Thangaraj Suresh

机构信息

School of Chemical Sciences, Department of Chemistry, Bharathiar University Coimbatore Tamil Nadu 641046 India

Disease Proteomics laboratory, School of Life Sciences, Department of Zoology, Bharathiar University Coimbatore Tamil Nadu 641046 India.

出版信息

RSC Med Chem. 2023 May 17;14(7):1331-1343. doi: 10.1039/d3md00165b. eCollection 2023 Jul 20.

DOI:10.1039/d3md00165b
PMID:37484570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10357927/
Abstract

A new series of 8-nitroquinolone-based aromatic heterocyclic acyl hydrazones have been synthesised and characterised through various spectroscopic techniques. They were theoretically examined for molecular docking with various proteins related to the apoptosis of the non-small cell lung cancer cell line A549. The results indicate that the possible modes of interaction of all the synthesised compounds are compatible for use as anti-proliferative drugs. Also, the drug-likeness of the compounds was examined through theoretical ADMET analysis, which indicated good gastrointestinal absorption as well as low toxicity. Selected compounds were evaluated for their anti-cancer activity using A549, MCF-7 and HeLa cell lines through an MTT assay to determine cytotoxicity. Compounds 3c, 3a and 11c exhibited significant cytotoxicity towards A549 cells in the order of 3c (15.3 ± 0.7) > 3a (15.8 ± 0.1) > 11c (17.1 ± 0.2), whereas all the compounds show insignificant toxicity on normal human embryonic kidney cells up to a concentration of 200 μM. The best compounds among the series (3c and 11c) were chosen for further detection of apoptosis through fluorescence microscopic techniques using AO/EtBr and DAPI. The reduced DNA synthesis during the cell cycle was also investigated through flow cytometric techniques. The results indicate that the compounds possess significant anticancer properties due to the activation of the mitochondrial mediated intrinsic pathway.

摘要

合成了一系列新型的基于8-硝基喹啉酮的芳香杂环酰腙,并通过各种光谱技术对其进行了表征。对它们与非小细胞肺癌细胞系A549凋亡相关的各种蛋白质进行了分子对接的理论研究。结果表明,所有合成化合物的可能相互作用模式都适合用作抗增殖药物。此外,通过理论ADMET分析研究了这些化合物的类药性质,结果表明它们具有良好的胃肠道吸收以及低毒性。通过MTT法使用A549、MCF-7和HeLa细胞系对所选化合物的抗癌活性进行了评估,以确定细胞毒性。化合物3c、3a和11c对A549细胞表现出显著的细胞毒性,顺序为3c(15.3±0.7)>3a(15.8±0.1)>11c(17.1±0.2),而所有化合物在浓度高达200μM时对正常人胚肾细胞均无明显毒性。选择该系列中最佳的化合物(3c和11c),通过使用AO/EtBr和DAPI的荧光显微镜技术进一步检测细胞凋亡。还通过流式细胞术研究了细胞周期中DNA合成的减少情况。结果表明,这些化合物由于激活了线粒体介导的内在途径而具有显著的抗癌特性。

相似文献

1
Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents.硝基喹诺酮稠合酰腙作为非小细胞肺癌药物的抗增殖活性。
RSC Med Chem. 2023 May 17;14(7):1331-1343. doi: 10.1039/d3md00165b. eCollection 2023 Jul 20.
2
Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies.基于碳硫酰胺/羧酰胺的吡唑啉类似物作为潜在抗癌剂的设计与合成:细胞凋亡、分子对接、ADME 分析及 DNA 结合研究
ACS Omega. 2022 Jun 23;7(26):22639-22656. doi: 10.1021/acsomega.2c02033. eCollection 2022 Jul 5.
3
Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, ADME and Molecular Docking Studies.酰肼腙类小分子原肌球蛋白受体激酶A(TRKA)抑制剂:合成、抗癌活性、药物代谢动力学及分子对接研究
Med Chem. 2022;19(1):47-63. doi: 10.2174/1573406418666220427105041.
4
Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.半笼型金属铂(II)配合物作为抗癌剂:分子对接、细胞凋亡、细胞周期分析和细胞毒性活性评价。
Anticancer Agents Med Chem. 2022;22(6):1149-1158. doi: 10.2174/1871520621666210713112105.
5
Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.新型咪唑并噻唑-噻唑烷酮杂合体的设计、合成、生物评价及分子模拟研究作为潜在的抗癌和抗炎药物。
Sci Rep. 2024 Apr 11;14(1):8457. doi: 10.1038/s41598-024-59063-x.
6
New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell Lines.新型偕异恶唑基二茂铁甲酸盐的合成、表征、X 射线晶体学及对 A549、HCT116 和 MCF-7 细胞系的初步细胞毒性研究。
Curr Pharm Des. 2022;28(34):2835-2841. doi: 10.2174/1381612828666220822113738.
7
Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.四唑连接的苯并色烯衍生物的合成、分子对接研究及体外抗癌活性
Anticancer Agents Med Chem. 2017;17(3):464-470. doi: 10.2174/1871520616666160627090249.
8
Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.新型嘧啶基腙类化合物的设计、合成及其对MCF-7和MDA-MB-231人乳腺癌细胞系的选择性抗增殖活性的分子对接研究
Bioorg Chem. 2023 Sep;138:106610. doi: 10.1016/j.bioorg.2023.106610. Epub 2023 May 16.
9
A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.作为非小细胞肺癌和结直肠癌靶向治疗潜在抗癌剂的新型三唑并噻二嗪系列:设计、合成、计算机模拟和体外研究,深入了解其抗癌潜力的作用机制。
Med Chem. 2021;17(10):1104-1128. doi: 10.2174/1573406416666201021142832.
10
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.新型查尔酮-噻吩嘧啶衍生物在 HepG2 和 MCF-7 细胞系中的合成、抗癌评估和分子对接。
Oxid Med Cell Longev. 2021 Dec 28;2021:4759821. doi: 10.1155/2021/4759821. eCollection 2021.

引用本文的文献

1
Expanding potential of quinoline hydrazide/hydrazone derivatives as anticancer agents.喹啉酰肼/腙衍生物作为抗癌剂的扩展潜力。
Future Med Chem. 2024 Jul 2;16(13):1283-1286. doi: 10.1080/17568919.2024.2366150. Epub 2024 Jun 27.

本文引用的文献

1
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases.8-羟基喹啉硝酮作为治疗神经退行性疾病的多功能配体。
Acta Pharm Sin B. 2023 May;13(5):2152-2175. doi: 10.1016/j.apsb.2023.01.013. Epub 2023 Jan 19.
2
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action.发现小分子 COX-1 和 Akt 抑制剂作为具有抗炎作用的抗 NSCLC 药物。
Int J Mol Sci. 2023 Jan 31;24(3):2648. doi: 10.3390/ijms24032648.
3
Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.新型 7-氯-4-氨基喹啉-苯并咪唑杂合体作为癌细胞生长抑制剂的研究:合成、抗增殖活性、体内 ADME 预测和对接。
Molecules. 2023 Jan 5;28(2):540. doi: 10.3390/molecules28020540.
4
Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities.发现新型吡啶-喹啉杂合体作为竞争性和非竞争性 PIM-1 激酶抑制剂,具有诱导细胞凋亡和激活 caspase 3/7 的能力。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2152810. doi: 10.1080/14756366.2022.2152810.
5
Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.喹啉-咪唑/苯并咪唑衍生物作为具有抗癌和抗菌活性的双重/多靶标杂合抑制剂。
Sci Rep. 2022 Oct 10;12(1):16988. doi: 10.1038/s41598-022-21435-6.
6
Discovery of hydrazide-based pyridazino[4,5-]indole scaffold as a new phosphoinositide 3-kinase (PI3K) inhibitor for breast cancer therapy.发现基于酰肼的哒嗪并[4,5-]吲哚支架作为一种用于乳腺癌治疗的新型磷酸肌醇3-激酶(PI3K)抑制剂。
RSC Adv. 2020 May 21;10(33):19534-19541. doi: 10.1039/d0ra02798g. eCollection 2020 May 20.
7
Platinum-based drugs for cancer therapy and anti-tumor strategies.铂类药物用于癌症治疗和抗肿瘤策略。
Theranostics. 2022 Feb 7;12(5):2115-2132. doi: 10.7150/thno.69424. eCollection 2022.
8
Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021.缺氧激活型抗癌药物前药衍生物:专利审查(2006-2021 年)
Expert Opin Ther Pat. 2022 Jan;32(1):1-12. doi: 10.1080/13543776.2021.1954617. Epub 2021 Jul 28.
9
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets.喹啉类抗肿瘤药物对 DNA 及 DNA 相互作用蛋白的作用:从经典治疗靶点到新兴治疗靶点。
Eur J Med Chem. 2021 Aug 5;220:113555. doi: 10.1016/j.ejmech.2021.113555. Epub 2021 May 24.
10
New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy.对 Bcl-2 家族抗凋亡成员在黑色素瘤进展和治疗中的作用的新认识。
Drug Discov Today. 2021 May;26(5):1126-1135. doi: 10.1016/j.drudis.2021.01.027. Epub 2021 Feb 2.